For the Inventor, By the Inventor

Enter assignee name

Houston, TX, United States of America

Agennix Incorporated

Calculating rank

USPTO Granted Patents = 20

% Expired Patents = 85.0

EPO Patents = 3

Forward Citations = 141

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Atul Varadhachary (16 out of 16 patents)

Jose Engelmayer (8 out of 8 patents)

Karel Petrak (6 out of 6 patents)

4. Federica Pericle (5 out of 5 patents)

5. Peter Glynn (4 out of 11 patents)

6. Yenyun Wang (3 out of 3 patents)

7. Bert W O'Malley (2 out of 40 patents)

8. Rick Barsky (2 out of 2 patents)

9. David Mann (2 out of 10 patents)

10. Orla M Conneely (2 out of 13 patents)

11. Denis R Headon (2 out of 10 patents)

12. Atul Varadhachary (4 patents)

13. Frederica Pericle (0 patent)

20 patents: Sort by Forward Citations

1. 8247373 - Lactoferrin compositions and methods of wound treatment (2012-08-21),

2. 8242079 - Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases (2012-08-14),

3. 8105615 - Lactoferrin as an adjuvant in cancer vaccines (2012-01-31),

4. 8058234 - Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease (2011-11-15),

5. 8030272 - Lactoferrin compositions and methods of wound treatment (2011-10-04),

6. 7901879 - Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases (2011-03-08),

7. 7638487 - Lactoferrin in the reduction of pain (2009-12-29),

8. 7592306 - Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease (2009-09-22),

9. 7524814 - Lactoferrin compositions and methods of wound treatment (2009-04-28),

10. 7420033 - Composition of lactoferrin related peptides and uses thereof (2008-09-02),

11. 7323443 - Lactoferrin in the reduction of pain (2008-01-29),

12. 7262279 - Lactoferrin in the treatment of diabetes mellitus (2007-08-28),

13. 7244706 - Antimicrobial/endotoxin neutralizing polypeptide (2007-07-17),

14. 7238661 - Oral lactoferrin in the treatment of respiratory disorders (2007-07-03),

15. 7183381 - Composition of lactoferrin related peptides and uses thereof (2007-02-27),

Company Overview

Agennix Incorporated is a biopharmaceutical company based in Houston, Texas, specializing in the development of innovative therapies for cancer and other serious diseases. The organization focuses on advancing its proprietary technologies to create targeted treatments that address unmet medical needs. With a commitment to research and development, Agennix aims to improve patient outcomes through its novel therapeutic approaches, leveraging expertise in oncology and related fields.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

20 Patents

#264 in Houston, TX

#975 in Texas

#16,416 in US

#31,315 in the World

Houston, TX, United States of America

Agennix Incorporated

Forward Citations = 141

11 inventors:

Atul Varadhachary (16 out of 16 patents)

Jose Engelmayer (8 out of 8 patents)

Karel Petrak (6 out of 6 patents)

4. Federica Pericle (5 out of 5 patents)

5. Peter Glynn (4 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Agennix Incorporated. Retrieved from https://idiyas.com/company/agennix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…